Chester County News and Community Website
WASHINGTON, D.C. — Federal health officials are moving to speed the development of psychedelic-based treatments for serious mental illness, following a new executive order aimed at expanding access to emerging …
FDA Moves to Fast-Track Psychedelic Mental Health Treatments Read More
WASHINGTON, D.C. — A new higher-dose version of a widely used weight loss drug has been approved on an accelerated timeline, offering patients another treatment option as federal regulators test …
FDA Fast-Tracks Higher-Dose Weight Loss Drug Approval Read More
WASHINGTON, D.C. — The Food and Drug Administration moved aggressively in mid-December to speed promising drug reviews, loosen long-standing evidence barriers, strengthen food recall enforcement, and court private-sector innovation, signaling …
FDA Accelerates Cures, Cracks Down on Recalls, and Rewrites the Rules of Review Read More
WASHINGTON, D.C. — The Food and Drug Administration rolled out a rapid-fire series of moves this month that could reshape how Americans manage chronic disease, treat rare and life-threatening blood …
FDA’s Week of Breakthroughs: New Gene Therapy, New Antibiotics, New Rules Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has awarded nine companies priority review vouchers under its new Commissioner’s National Priority Voucher (CNPV) pilot program, designed to accelerate approval …
FDA Names Nine Recipients in New Fast-Track Program for High-Priority Drugs Read More
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to their supplemental Biologics License Application (sBLA) for …
FDA Grants Priority Review for ENHERTU Combo in Advanced Breast Cancer Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration has granted accelerated approval to Forzinity (elamipretide) injection, the first treatment for Barth syndrome, a rare and life-threatening mitochondrial disease that …
FDA Approves First Drug for Rare, Fatal Barth Syndrome Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) announced a series of actions last week aimed at strengthening consumer protections, advancing rare disease treatment development, and improving drug …
FDA Issues Series of Regulatory Actions Targeting Public Health, Transparency, and Drug Safety Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has unveiled the Commissioner’s National Priority Voucher (CNPV) program, aiming to streamline the drug approval process and address critical health …
FDA Introduces Priority Voucher Program to Accelerate Drug Approvals Read More